Volume : 08, Issue : 12, December – 2021
Title:
01.FORMULATION AND IN-VITRO EVALUATION OF TASTE MASKED ORALLY DISINTEGRATING
TABLETS OF A BITTER BCS CLASS II DRUG
Authors :
Yarlagadda Triveni*, Madhu Gudipati, Adilakshmi Challa and S. Manohar Babu
Abstract :
The present study concerns to mask the bitter taste of Ibuprofen as an orally disintegrating tab-let using Eudragit EPO (Film former) as a taste masking agent. FT-IR spectrometries were used to investigate the compatibility of drug: resin complex. Six batches (F1, F2, F3, F4, F5, and F6) of orally disintegrating tablets were prepared by wet granulation method with super disintegrant like Crosscarmellose sodium, Crospovidone. The granules were evaluated for pre-compression parameters like angle of repose, bulk density, tapped density, compressibility index and Hausner’s ratio. And post-compression parameters like weight variation, thickness, hardness, friability, and in-vitro disintegration and in-vitro dissolution tests. The results indicate that orally disintegrating tablets of Ibuprofen containing Eudragit EPO provides good taste and better option for quick disintegration and fast release and improved bioavailability. Therefore to ensure faster drug release, a water soluble excipient, lactose was added to the pellets. Coating of Ibuprofen loaded MCC-Lactose pellets with Eudragit EPO masked the taste and increased the drug release profile by 12% in 30 min.
Cite This Article:
Please cite this article in press Yarlagadda Triveni et al, Formulation and in-vitro Evaluation Of Taste Masked Orally Disintegrating Tablets of A Bitter BCS Class II Drug., Indo Am. J. P. Sci, 2021; 08(12).
Number of Downloads : 10
References:
1. James Swarbrick, Drug delivery: Oral route, Encyclopedia of pharmaceutical technology”, 3rd edition, Vol 1: pp.1242.
2. Gilbert S. Banker, Christopher T. Rhodes, Tablet dosage form, Modern Pharmaceutics, 4th edition, pp.287
3. www.pua.cc/PUASite
4. Shyamala B, Narmada GY. Rapid dissolving tablets: A novel dosage form. The Indian Pharmacist, 2012; 13(8): 09-12.
5. Valleri M, Mura P, Maestrelli F, Cirri M, Ballerini R.. Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique. Drug Dev Ind Pharm, 2004; 30(5): 525-34.
6. Hanawa T, Watanabe A, Tsuchiya T, Ikoma R, Hidaka M, Sugihara M., New Oral dosage form for elderly patients: Preparation and characterization of silk fibroin gel. Chem Pharm Bull, 1995; 43(2): 284-288.
7. Mallet L. Caring for the Elderly Patient. J. Am. Pharm. Assoc, 1996; 36(11): 628-635.
8. Porter SC. Novel drug delivery: Review of recent trends with oral solid dosage forms. Am Pharm Rev, 2001; 85: 28-35.
9. Deepak K., Orally disintegrating tablets. Tablets and Capsules, 2014; 7: 30-35.
10. Brown D. Orally disintegrating tablets: Taste over speed. Drug Deliv Tech, 2001; 3(6): 58-61.
11. US Food and Drug Administration, CDER Data Standards Manual. 2003. www.fda.gov/cder/dsm/DRG/drg00201.htm. Accessed 6 February 2007.
12. European Directorate for quality of Medicines. Pharmaeuropa. 1998; 10(4): 547. http://www.pheur.org. Accessed 6 February 2007.
13. Ghosh TK, Chatterjee DJ, Pfister WR. Quick dissolving oral dosage forms: Scientific and regulatory considerations from a clinical pharmacology and biopharmaceutical perspective. In: Ghosh TK and Pfister WR (Eds). Drug Delivery to the Oral Cavity: Molecules to Market. NY, USA: CRC Press, 2005, pp 337-356.
14. Lies MC, Atherton AD, Copping NM. Freeze-dried dosage forms and methods for preparing same. US Patent 5,188,825 (1993).
15. Ostrander K. Advances in fast dispersing technologies-zydis. Paper presented at the Annual Meeting of the AAPS, Salt Lake City, UT, 2013, 29 Oct.
16. Sharma S. New generation of tablet: fast dissolving tablet. http://www.pharmainfo.net.
17. Suresh Bandari, Rajendra Kumar Mittapalli. Orodispersible Tablets. Asian Journal of Pharmaceutics, 2008; pp. 2-11
18. Habib W, Khankari RK, Hontz J. Fast-dissolve drug delivery systems. Crit Rev Ther Drug Carrier Sys 2010; 17, pp. 61-72
19. Dobetti L. Fast-melting tablets: Developments and technologies. Pharm Technol N Am 2001; pp. 44-50
20. Van Scoik KG. Solid Pharmaceutical dosage in tablet triturate form and method of producing the same. US Patent 5,082,667.
21. Meyers GL, Battist GE, Fuisz RC. Process and apparatus for making rapidly dissolving dosage units and product Thereform. PCT Patent WC 95/34293-A1; 1995.
22. Allen LV, Wang B. Process for making a particulate support matrix for making a rapidly dissolving dosage form. US Patent 6,207,199; 2001.
23. Bhaskaran S, Narmada GV. Rapid Dissolving tablet A Novel dosage form Indian Pharmacist 2002, 1, pp. 9-12
24. Abdelbary G, Prinderre P, Eouani C, Joachim J, Reynier JP, Piccerelle P. The preparation of orally disintegrating tablets using a hydrophilic waxy binder. Int J Pharm 2004; 278, pp. 423-433.
25. Kuno Y, Kojima M, Ando S, Nakagami H. Evaluation of rapidly disintegrating tablets manufactured by phase transition of sugar alcohols. J Control Release 2005; 105, pp. 16-22.